Results
915
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
915 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
IGTI3 | R$2.18 | 6.3% | -24.0% | R$5.1b | R$32.50 | PE7x | E20.3% | 3.0% | Real Estate Management and Development | ||
3526 | NT$264.50 | 0% | 40.3% | NT$16.6b | NT$350.00 | PE18.4x | E25.1% | 4.3% | Tech | ||
DATA | UK£1.78 | -1.9% | -11.0% | UK£1.4b | UK£2.66 | PE42.6x | E25.8% | 2.6% | Commercial Services | ||
PWG | €0.58 | 0.3% | -44.1% | €29.7m | €0.66 | PS0.5x | E118.8% | n/a | Capital Goods | ||
ARRY | US$7.33 | 3.4% | -46.4% | US$1.1b | US$10.10 | PS1.1x | E65.1% | n/a | Capital Goods | ||
300820 | CN¥50.58 | -2.4% | 42.6% | CN¥11.1b | CN¥58.00 | PE24.5x | E26.3% | 0.8% | Capital Goods | ||
GMR | UK£0.36 | -2.2% | -4.5% | UK£105.5m | UK£0.54 | PE15.7x | E22.1% | n/a | Media | ||
S32 | AU$3.36 | -5.1% | 0.6% | AU$15.1b | AU$3.81 | PS1.7x | E52.0% | 1.7% | Materials | ||
EGLA | €2.60 | 5.9% | -15.7% | €423.6m | €4.84 | PE18x | E43.1% | 1.6% | Capital Goods | ||
688046 | CN¥13.06 | -3.2% | 10.6% | CN¥5.3b | CN¥14.00 | PE38.3x | E24.2% | 0.5% | Pharmaceuticals & Biotech | ||
1818 | HK$12.14 | -2.7% | 57.7% | HK$41.3b | HK$16.58 | PE32x | E38.6% | 0.4% | Materials | ||
A248070 | ₩18,850.00 | -0.5% | -30.6% | ₩907.4b | ₩31,625.00 | PE20.4x | E50.0% | n/a | Tech | ||
IDX | AU$3.12 | 6.1% | 58.4% | AU$1.2b | AU$3.40 | PS2.5x | E54.6% | 1.9% | Healthcare | ||
GROY | US$1.32 | 5.6% | -2.9% | US$216.7m | US$3.02 | PS28.8x | E171.6% | 0% | Materials | ||
BUFAB | SEK 467.40 | 1.7% | 26.7% | SEK 17.7b | SEK 467.50 | PE34.7x | E20.8% | 1.1% | Capital Goods | ||
7373 | JP¥1,825.00 | 3.7% | -9.8% | JP¥27.9b | JP¥4,700.00 | PE18.7x | E23.1% | 1.6% | Commercial Services | ||
IEL | AU$13.34 | 3.7% | -30.9% | AU$3.7b | AU$18.17 | PE28x | E13.8% | 2.5% | Consumer Services | ||
1813 | JP¥2,195.00 | 2.0% | -3.7% | JP¥33.2b | JP¥3,100.00 | PE25.4x | E35.1% | 2.7% | Capital Goods | ||
BILI | US$16.72 | -1.0% | 87.0% | US$7.3b | US$23.41 | PS2x | E64.9% | n/a | Media | ||
ERIC B | SEK 83.86 | -1.6% | 47.6% | SEK 279.5b | SEK 84.21 | PE13973.9x | E47.5% | 3.4% | Tech | ||
AGNC | US$9.97 | 3.0% | 4.4% | US$9.0b | US$10.17 | PE12.2x | E23.4% | 14.4% | Diversified Financials | ||
300702 | CN¥17.32 | 0.4% | 9.8% | CN¥6.0b | CN¥22.42 | PE136.4x | E71.4% | 0.3% | Pharmaceuticals & Biotech | ||
VRRM | US$26.39 | -1.2% | 12.8% | US$4.4b | US$29.17 | PE43x | E23.5% | n/a | Commercial Services | ||
VCT | UK£9.92 | -0.4% | -26.7% | UK£862.9m | UK£12.51 | PE50.2x | E29.0% | 6.0% | Materials |